0

CMHC PULSE

Cardio Metabolic Health Congress – Official Blog

Familial Hypercholesterolemia Awareness Day is September 24, 2015

Familial hypercholesterolemia (FH) affects up to 1.3 million people in the United States, of whom 90% have not been properly diagnosed or treated. Many individuals with FH have no visible symptoms, and untreated, are at an excessively high risk of having an early heart attack—20 times higher. Early diagnosis and treatment are crucial to change these statistics.

The FH Foundation is a patient-centered nonprofit organization dedicated to education, advocacy, and research of all forms of FH. Their mission is to raise awareness and save lives by increasing the rate of early diagnosis and encouraging proactive treatment. The FH Awareness Tweet-a-Thon, which will focus on the signs, symptoms, and risks of FH, will take place Thursday, September 24 at 5 pm PST, 7 pm CST, and 8 pm EST. Join the conversation at: https.//twitter.com/TheFHFoundation. #KnowFH. Also, plan to join us at the 10th Annual CMHC #CMHC 2015 on October 21-24 and visit our booth at the CMHC Exhibitor Showcase to speak with representatives from the FH Foundation. Read more

More Aggressive Management of Hypertension Reduces Rates of CVD, Lowers Mortality Risk

Initial results of SPRINT (Systolic Blood Pressure Intervention Trial), a landmark clinical trial sponsored by the NIH, have shown that more aggressive management of hypertension significantly reduces the rate of cardiovascular disease and lowers the risk of mortality in a group of adults 50 years of age and older with hypertension. The trial, which began in 2009, consisted of more than 9300 participants 50 years of age and older. Participants were divided into two groups. The standard group, with a target systolic blood pressure of less than 140 mmHg, received an average of two different antihypertensive medications. The intensive treatment group received an average of three antihypertensive medications for a target systolic blood pressure of less than 120 mmHg.

Compared with the standard group, the intensive treatment group experienced an almost one-third reduction in rates of cardiovascular events, including myocardial infarction and heart failure as well as stroke. Risk of mortality was reduced by almost one fourth.

For the most up-to-date information on this study as well as other developments, plan to attend the Hypertension and Cardio-Renal Syndrome session at the 10th Annual CMHC on Friday, October 23.

Reference: Landmark NIH study shows intensive blood pressure management may save lives.